<code id='6C1EA6C1E9'></code><style id='6C1EA6C1E9'></style>

<acronym id='6C1EA6C1E9'></acronym>

<center id='6C1EA6C1E9'><center id='6C1EA6C1E9'><tfoot id='6C1EA6C1E9'></tfoot></center><abbr id='6C1EA6C1E9'><dir id='6C1EA6C1E9'><tfoot id='6C1EA6C1E9'></tfoot><noframes id='6C1EA6C1E9'>

<optgroup id='6C1EA6C1E9'><strike id='6C1EA6C1E9'><sup id='6C1EA6C1E9'></sup></strike><code id='6C1EA6C1E9'></code></optgroup>

<b id='6C1EA6C1E9'><label id='6C1EA6C1E9'><select id='6C1EA6C1E9'><dt id='6C1EA6C1E9'><span id='6C1EA6C1E9'></span></dt></select></label></b><u id='6C1EA6C1E9'></u>

~~<i id='6C1EA6C1E9'><strike id='6C1EA6C1E9'><tt id='6C1EA6C1E9'><pre id='6C1EA6C1E9'></pre></tt></strike></i>~~

Home» knowledge» focus

focus

focus

author：focus 2025-09-30 04:39:56 Page View：9

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

advertisement

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Juul documents reveal insider tactics on political lobbying
Next article： State Dept. review finds Biden bears some blame for Afghanistan failures

leisure time

In Memoriam: Notable people who died in 2023

In Memoriam: Notable people who died in 2023

1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

What we’ve learned from the Aduhelm mess

What we’ve learned from the Aduhelm mess

MollyFergusonforSTATSTATnowpublishesselectedLetterstotheEditorreceivedinresponsetoFirstOpinionessays

BioMarin wins approval for gene therapy to treat hemophilia A

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

Why Eli Lilly’s earnings didn’t quite live up to the hype

KristofferTripplaar/APEventually,theluckiestcompaniesgettodealwithaveryparticularproblem:whattodowhe

read more